Perspective Perspectives are commissioned from an expert and discuss the clinical practice or public health implications of a published study. The original publication must be freely available online.

See all article types »

How Industry Uses the ICMJE Guidelines to Manipulate Authorship—And How They Should Be Revised

  • Alastair Matheson mail

    Affiliation: Independent Consultant, London, United Kingdom and Toronto, Canada

  • Published: August 09, 2011
  • DOI: 10.1371/journal.pmed.1001072

About the Author

Alastair Matheson
Independent Consultant, London, United Kingdom and Toronto, Canada

Corresponding Author


Competing Interests

For over 15 years AM has been partially dependent on the pharmaceutical and biotechnology industries for his income, providing consultancy and writing services as a freelance contractor. This experience has been both directly with corporations and, more frequently, with medical communications agencies. Currently he spends about 25% of his time on industry-related work and currently makes about 50% of his income from it. The rest of his time he spends working as an independent consultant with Fondation ARCAD, an academic organization for oncology research based in France, and in academic research, principally in cancer biology and science studies.

Author Contributions

ICMJE criteria for authorship read and met: AM. Agree with manuscript's results and conclusions: AM. Wrote the first draft: AM.